Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Hopf

Showing results (161-170 of 179) with videos related to

Pageof 18
Sort By:
Clinical Transplantation|June 1, 1995
The optimal immunosuppressant after liver transplantation according to diagnosis: cyclosporine A or FK506?A R Mueller, K P Platz, G Blumhardt, et al.
Transplantation Proceedings|February 1, 1995
The superior immunosuppressant according to diagnosis: FK 506 or cyclosporine AA R Mueller, K P Platz, G Blumhardt, et al.
Zeitschrift Fur Arztliche Fortbildung|September 10, 1992
[Risks and prevention in orthotopic liver transplantation and persistent infection with hepatitis type B and type delta viruses]U Hopf, P Neuhaus, V König, et al.
Liver|February 13, 2001
Efficacy of a short-term ribavirin plus interferon alpha combination therapy followed by interferon alpha alone in previously untreated patients with chronic hepatitis C: a randomized multicenter trialT Berg, R M Hoffmann, G Teuber, et al.
Zeitschrift Fur Gastroenterologie|September 1, 1992
[Orthotopic liver transplantation in hepatic cirrhosis: on the problem of infection of the transplant with persistent hepatitis viruses]U Hopf, P Neuhaus, V König, et al.
Journal of Hepatology|January 1, 1990
Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV)U Hopf, B Möller, D Küther, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
Isolation and preliminary characterization of human mononuclear liver cellsH U Jahn, R Ullrich, T Schneider, et al.
Transplantation Proceedings|February 1, 1997
Impact of immunosuppression and acute rejection on hepatitis B recurrenceK P Platz, A R Mueller, G W Haller, et al.
Zeitschrift Fur Gastroenterologie|September 24, 1999
Interferon-antibodies and the breakthrough phenomenon during ribavirin/interferon-alpha combination therapy and interferon-alpha monotherapy of patients with chronic hepatitis CR M Hoffmann, T Berg, G Teuber, et al.
Transplantation Proceedings|December 1, 1996
Long-term follow-up in hepatitis C patients with respect to immunosuppressionA R Mueller, K P Platz, T Berg, et al.
Pageof 18

Showing results (161-170 of 179) with videos related to

Sort By:
Pageof 18
Clinical Transplantation|June 1, 1995
The optimal immunosuppressant after liver transplantation according to diagnosis: cyclosporine A or FK506?A R Mueller, K P Platz, G Blumhardt, et al.
Transplantation Proceedings|February 1, 1995
The superior immunosuppressant according to diagnosis: FK 506 or cyclosporine AA R Mueller, K P Platz, G Blumhardt, et al.
Zeitschrift Fur Arztliche Fortbildung|September 10, 1992
[Risks and prevention in orthotopic liver transplantation and persistent infection with hepatitis type B and type delta viruses]U Hopf, P Neuhaus, V König, et al.
Liver|February 13, 2001
Efficacy of a short-term ribavirin plus interferon alpha combination therapy followed by interferon alpha alone in previously untreated patients with chronic hepatitis C: a randomized multicenter trialT Berg, R M Hoffmann, G Teuber, et al.
Zeitschrift Fur Gastroenterologie|September 1, 1992
[Orthotopic liver transplantation in hepatic cirrhosis: on the problem of infection of the transplant with persistent hepatitis viruses]U Hopf, P Neuhaus, V König, et al.
Journal of Hepatology|January 1, 1990
Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV)U Hopf, B Möller, D Küther, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
Isolation and preliminary characterization of human mononuclear liver cellsH U Jahn, R Ullrich, T Schneider, et al.
Transplantation Proceedings|February 1, 1997
Impact of immunosuppression and acute rejection on hepatitis B recurrenceK P Platz, A R Mueller, G W Haller, et al.
Zeitschrift Fur Gastroenterologie|September 24, 1999
Interferon-antibodies and the breakthrough phenomenon during ribavirin/interferon-alpha combination therapy and interferon-alpha monotherapy of patients with chronic hepatitis CR M Hoffmann, T Berg, G Teuber, et al.
Transplantation Proceedings|December 1, 1996
Long-term follow-up in hepatitis C patients with respect to immunosuppressionA R Mueller, K P Platz, T Berg, et al.
Pageof 18